Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative-Reference-Cited by-同舟云学术

Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative

Published:2013-04-09 Issue:2-3 Volume:56 Page:358-361
ISSN:0257-277X
Container-title:Immunologic Research
language:en
Short-container-title:Immunol Res

Author:

Coloma Bazán Emmanuel,Donate López Carolina,Moreno Lozano Pedro,Cervera Ricard,Espinosa Gerard

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1007/s12026-013-8407-x.pdf

Reference18 articles.

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295.

2. Ruiz-Irastorza G, Crowther M, Branch DW, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376(9751):1498.

3. Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, et al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of the 13th international congress on antiphospholipid antibodies. Lupus. 2011;20:206.

4. Martinez-Zamora MA, Peralta S, Creus M, et al. Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study. Ann Rheum Dis. 2012;71:61.

5. Gris JC, Bouvier S, Molinari N, et al. Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study. Blood. 2012;119:2624.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiphospholipid antibody-related hepatic vasculitis in a juvenile after non-severe COVID-19: a case report and literature review;Frontiers in Immunology;2024-04-19

2. Deciphering the clinical significance of longitudinal antiphospholipid antibody titers;Autoimmunity Reviews;2024-03

3. Adrenal hemorrhage and non-ST elevation myocardial infarction: an antiphospholipid syndrome dilemma;Reumatismo;2023-09-18

4. Antiphospholipid Syndrome: State of the Art of Clinical Management;Cardiovascular Drugs and Therapy;2023-08-12

5. Recurrent thrombotic events after disappearance of antiphospholipid autoantibodies: A long-term longitudinal study in patients with antiphospholipid syndrome;Thrombosis Research;2023-04